Labetuzumab govitecan

Ask supplier a question | View on supplier's website

Labetuzumab govitecan (IMMU-135) is a humanised anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody linked site-specifically to the active metabolite of irinotecan SN-38 via a proprietary linker. Labetuzumab govitecan can be used for research on colorectal cancer.

Supplier	Selleck Chemicals
Product #	D4048
Sku #	D4048-1mg*5
Pricing	1mg*5, $2890.00

Feedback